UT Southwestern Medical Center is recognized by the PTEN Hamartoma Tumor Syndrome Foundation as a PTEN Clinical Center of Excellence. This means that our team has outstanding expertise in handling the health care needs of individuals with PHTS.
Cancer Risks Associated with a PTEN Mutation
Females with a PTEN P/LP variant may have more than a 60% lifetime risk for breast cancer and up to a 30% lifetime risk for uterine cancer. Males and females with the variant have up to a 35% lifetime risk for thyroid cancer, up to a 35% lifetime risk for kidney cancer, a 20% lifetime risk for colon cancer, and a 5-10% risk for melanoma (skin cancer).